Xenon Pharmaceuticals, Inc. (XENE)
43.79
+1.24
(+2.91%)
USD |
NASDAQ |
Mar 03, 16:00
43.80
+0.01
(+0.02%)
After-Hours: 06:48
Xenon Pharmaceuticals Total Liabilities (Quarterly) : 399.91M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 189.26M |
| Oncolytics Biotech, Inc. | 10.74M |
| Edesa Biotech, Inc. | 0.7562M |
| Lexaria Bioscience Corp. | 1.527M |
| ProMIS Neurosciences, Inc. | 12.27M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 981.67M |
| Shareholders Equity (Quarterly) | 581.76M |
| Debt to Equity Ratio | 0.0137 |
| Current Ratio | 13.42 |
| Net Debt Paydown Yield | 0.01% |